Viewing nowSolshinjeong 10 mg (Solifenacin Succinate)
Solifenacin Succinate 10mg
Tablet · Prescription medication
Aju Pharmaceutical Co., Ltd.

MFDS item code 201405043 · Approved 2014.10.30
Treatment of symptoms of overactive bladder (e.g., urge urinary incontinence and frequent urination)
This medication is used to treat the main symptoms of overactive bladder, such as urge incontinence, frequency, and urgency.
The usual recommended dose for adults (including older adults) is 5 mg once daily. If necessary, the dose may be increased to a maximum of 10 mg once daily. This medicine may be taken regardless of meals. Swallow the tablet whole with water. Dosage adjustment is necessary for the following patients. 1. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance >30ml/min). In patients with severe renal impairment (creatinine clearance≤30ml/min), administer with caution and do not exceed 5mg once daily. 2. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild hepatic impairment. In patients with moderate hepatic impairment (Child-Pugh Class B), administer with caution and do not exceed 5mg once daily. 3. Patients taking a strong cytochrome P450 3A4 (CYP3A4) inhibitor: In patients taking ketoconazole or another strong CYP3A4 inhibitor (e.g., ritonavir, nelfinavir, itraconazole), limit the maximum daily dose to 5mg.
This medication should not be used in patients with urinary retention symptoms that make it difficult to urinate. It should also not be administered to patients with serious gastrointestinal issues, myasthenia gravis, or angle-closure glaucoma where the pressure in the eye is raised. Patients who are allergic to this medication or any of its ingredients, those undergoing hemodialysis, and patients with severely impaired liver or kidney function should not use this medication. Caution is particularly required for patients with moderate to severe liver function impairment who are taking strong CYP3A4 inhibitors. Patients who are genetically unable to digest certain sugars should also avoid this medication. Patients at risk of urinary obstruction or with decreased gastrointestinal motility, as well as those with severe kidney or liver impairment, should have their dosage limited and be carefully monitored. The dosage may also need to be adjusted if taken with strong CYP3A4 inhibitors. Patients taking medications that may exacerbate gastroesophageal reflux disease or esophagitis, and those with autonomic nervous system disorders should use this medication with caution. This medication may cause dry mouth and constipation, and can cause blurred vision or dry eyes. Also, serious gastrointestinal issues may occur rarely, so if any abnormal symptoms appear, immediate consultation with a healthcare professional is required. Patients with heart disease or electrolyte imbalances may need to be cautious, as this medication can cause heart rhythm irregularities. If signs of angioedema or allergic reactions appear, discontinue the medication immediately and seek appropriate care. This medication may cause drowsiness, fatigue, or blurred vision, requiring caution when driving or operating machinery. Taking this medication with other anticholinergic drugs may increase its effects or side effects, so patients must inform their healthcare provider about any other medications they are taking. This medication is broken down by certain enzymes in the liver, so taking strong enzyme inhibitors together may increase the drug concentration, requiring dosage adjustment. Pregnant women should use this medication cautiously as its safety has not been established, and breastfeeding women should avoid it as it may pass into breast milk and affect the baby. It is advisable to avoid use in children as its safety and efficacy have not been confirmed. In the case of overdose, symptoms may include headache, dizziness, drowsiness, blurred vision, and in severe cases, emergency treatment may be necessary. If overdose is suspected, immediate medical attention should be sought.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing it in excessively hot or cold environments, and it is advisable to store it at room temperature between 1 and 30 degrees Celsius.
Bright pink round film-coated tablets
100 tablets (10 tablets/PTP*10)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSolifenacin Succinate 10mg
Tablet · Prescription medication
Aju Pharmaceutical Co., Ltd.

Solifenacin Succinate 10mg
Tablet · Prescription medication
Astellas Pharma Korea, Inc.

Solifenacin Succinate 5mg
Tablet · Prescription medication
Korea Astellas Pharma Co., Ltd.

Solifenacin Succinate 10mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Solifenacin Succinate 5mg
Tablet · Prescription medication
Withus Pharmaceutical Co., Ltd.

Solifenacin Succinate 10mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Solifenacin Succinate 10mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.

Solifenacin Succinate 5mg
Tablet · Prescription medication
Hankook Hyutex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.